
Montihill AM 75mg/5mg/10mg Tablet SR
Marketer
Scotwin Healthcare
Salt Composition
Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Overview Montihill AM 75mg/5mg/10mg Tablet SR
Respiflow AM 75mg/5mg/10mg Extended-Release Tablets are a multi-component medication indicated for managing respiratory illnesses characterized by thick mucus. This formulation offers relief from productive coughs associated with conditions such as bronchial asthma, bronchitis, and the common cold. Respiflow AM should be administered as directed by your physician, with or without food. Dosage is individualized based on your response and the severity of your condition. Continue the prescribed course of treatment; premature cessation may lead to symptom recurrence and disease exacerbation. Inform your doctor of all other medications you are currently using, as interactions are possible. Commonly reported side effects include nausea, indigestion, dry mouth, influenza-like symptoms, tiredness, and headache. These are typically transient and self-limiting. Report any concerning side effects promptly to your doctor. Drowsiness and dizziness may occur; avoid driving or activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential additive sedative effects. Prior to commencing treatment, disclose any kidney or liver impairment to allow for appropriate dosage adjustment. Pregnancy, pregnancy planning, or breastfeeding should also be reported to your physician.
Primary Ingredients of Montihill AM 75mg/5mg/10mg Tablet SR
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Montihill AM 75mg/5mg/10mg Tablet SR
Managing respiratory conditions characterized by thick mucus.
Major Benefits of Montihill AM 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Montihill AM 75mg/5mg/10mg Extended-Release Tablets may be consumed with or without food, although consistent timing is recommended.
Common Side effects of Montihill AM 75mg/5mg/10mg Tablet SR:
- Nausea
- Upset stomach
- Dryness in mouth
- Headache
- Fatigue
- Allergic reaction
- Sleepiness
- Flu-like symptoms
How to use Montihill AM 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Montihill AM 75mg/5mg/10mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.
How Montihill AM 75mg/5mg/10mg Tablet SR works:
Tri-Med 75mg/5mg/10mg Extended-Release Tablets combine ambroxol, levocetirizine, and montelukast to address respiratory symptoms. Ambroxol, a mucolytic agent, facilitates mucus expectoration. Levocetirizine, an antihistamine, targets allergic rhinitis manifestations such as nasal discharge, ocular itching, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thus lessening airway and nasal inflammation and alleviating symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Montihill AM 75mg/5mg/10mg SR tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The extended-release Montihill AM 75mg/5mg/10mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Montihill AM 75mg/5mg/10mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Montihill AM 75mg/5mg/10mg SR tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Montihill AM 75mg/5mg/10mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Montihill AM 75mg/5mg/10mg SR tablets are contraindicated in patients experiencing severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Montihill AM 75mg/5mg/10mg SR tablets cautiously. Dosage modification for Montihill AM 75mg/5mg/10mg SR tablets might be necessary. Physician consultation is advised.
What if you forget to take Montihill AM 75mg/5mg/10mg Tablet SR :
Should you forget a Montihill AM 75mg/5mg/10mg Tablet SR dose, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Montihill AM 75mg/5mg/10mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Breathing |
